# Exparel Injection for Postoperative Orbital Pain

> **NCT02381353** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 88 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT02381353
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381353, "Exparel Injection for Postoperative Orbital Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02381353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*